Original Research

Published on 13 Aug 2024

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Lu Wang
Shipeng Zhang
Hengxu Liu
Hongping Wang
Tao Liu
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432759

1,707 views
1 citation

Systematic Review

Published on 31 Jul 2024

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis

in Pharmacoepidemiology

Huifang Zhang
Yang Liu
Xiyu Shang
Yuqing Cao
Jiajia Li
Guangkun Chen
Xinyu Ji
Lei Zhang
Yipin Fan
Yan Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422773

947 views

Original Research

Published on 31 Jul 2024

The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

in Pharmacoepidemiology

Jungmi Chae
Ho Jin Cho
Sang-Heon Yoon
Dong-Sook Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382990

1,223 views

Original Research

Published on 26 Jul 2024

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacoepidemiology

Yanli Qiao
Yechao Chen
Qiaoyun Wang
Jingrui Liu
Xiaohui Guo
Qiaoling Gu
Peng Ding
Haixia Zhang
Hongliang Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413944

2,593 views

Review

Published on 24 Jul 2024

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

in Pharmacoepidemiology

Zhen Zeng
Hao Lin
Mingshan Jiang
Jing Yuan
Xi Li
Yongbin Jia
Li Yang
Hu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424606

1,594 views

Original Research

Published on 24 Jul 2024

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database

in Pharmacoepidemiology

Michael Magdy Fahmy Girgis
Gergely Farkasinszky
Klára Fekete
István Fekete
Miklós Vecsernyés
Ildikó Bácskay
László Horváth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411134

1,203 views

Original Research

Published on 24 Jul 2024

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system

in Pharmacoepidemiology

Liangxia Li
Qianqian Xu
Yarui Liu
Liangfang Pang
Zhou Cui
Yuanyuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403988

1,369 views

Original Research

Published on 22 Jul 2024

Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China

in Pharmacoepidemiology

Nan Shang
Xianlin Li
Zhiyu Guo
Lan Zhang
Shanshan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362345

846 views

Original Research

Published on 19 Jul 2024

Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis

in Pharmacoepidemiology

Yin Li
Yu Xiong
Wenxin Fan
Kai Wang
Qingqing Yu
Liping Si
Patrick van der Smagt
Jun Tang
Nutan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371504

932 views

Original Research

Published on 12 Jul 2024

How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels

in Pharmacoepidemiology

Alexander Tinchon
Joana Brait
Sascha Klee
Uwe Graichen
Christian Baumgartner
Oliver Friedrich
Elisabeth Freydl
Stefan Oberndorfer
Walter Struhal
Barbara Hain

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377232

682 views

Original Research

Published on 12 Jul 2024

Comparing the adverse effects of ketamine and esketamine between genders using FAERS data

in Pharmacoepidemiology

Xinxia Yang
Dongdong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329436

1,404 views

Original Research

Published on 10 Jul 2024

The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system

in Pharmacoepidemiology

Wei Wei
Liang Huang
Yingtao Bai
En Chang
Jinfeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391003

1,268 views

Original Research

Published on 04 Jul 2024

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases

in Pharmacoepidemiology

Shupeng Zou
Mengling Ouyang
Yazheng Zhao
Qian Cheng
Xuan Shi
Minghui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392914

2,246 views

Original Research

Published on 03 Jul 2024

Falls in hospitalized older adults and the use of fall risk-increasing drugs and anticholinergic medications in Colombia: a case‒control study

in Pharmacoepidemiology

Manuel E. Machado-Duque
Lina Camacho-Arteaga
Mónica Sabaté
Xavier Vidal-Guitart
Jorge E. Machado-Alba

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369200

1,059 views

Original Research

Published on 02 Jul 2024

Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database

in Pharmacoepidemiology

Feng Liu
Jing-xuan Zheng
Xiao-dan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365706

1,506 views

Original Research

Published on 28 Jun 2024

Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method

in Pharmacoepidemiology

Xiao Meng
Yaozhou Wu
Zixuan Liu
Yifan Chen
Zhizhou Dou
Li Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1322587

558 views

Navigation group

Articles

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis

The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system

Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China

Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis

How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels

Comparing the adverse effects of ketamine and esketamine between genders using FAERS data

The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases

Falls in hospitalized older adults and the use of fall risk-increasing drugs and anticholinergic medications in Colombia: a case‒control study

Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database

Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method